• where experts go to learn about FDA
  • Medical Devices

    • Managing Residual Risk – Words from the WiseAugust 22nd, 2007

      Hyman, Phelps & McNamara, P.C.’s Brian J. Donato cautioned companies about the dangers of “residual risk” while speaking at a recent conference on risk management sponsored by AdvaMed.  Medical Device & Diagnostic Industry reported on the speech in an August 2007 article.  Residual risk, which …

    • FDA Issues Second Draft Version of IVDMIA GuidanceJuly 25th, 2007

      FDA has released a new draft guidance for In Vitro Diagnostic Multivariate Index Assays (“IVDMIAs”).  The first version, which was released on September 7, 2006, attracted many critical comments.  The new draft seeks to address some (but not all) of those concerns. Creating a new …

    • Supreme Court to Hear Case Involving Scope of the Preemption Provision of the Medical Device AmendmentsJuly 8th, 2007

      On June 25, 2007, the Supreme Court agreed to hear Riegel v. Medtronic, Inc., which concerns whether the FDC Act preempts state tort claims regarding medical devices that entered the market pursuant to the Premarket Approval (“PMA”) process.  In 1996, the Supreme Court held in …

    • FDA Postponement of 2008 Annual Registration for All Registered Medical Device EstablishmentsJune 29th, 2007

      The FDA announced it is postponing the annual registration of medical device establishments for 2008. The agency said this is a temporary action and it expects to resume annual registrations in October or November 2007.  Establishments that are already registered for 2007 are valid until …

    • D.C. Court of Appeals Sidesteps Issue of FDA Classification of Dental Amalgam DevicesApril 24th, 2007

      On April 13, 2007, the U.S. Court of Appeals for the District of Columbia ruled in Moms Against Mercury v. FDA that the court lacks subject matter jurisdiction to decide whether FDA should classify “pre-amendment” Encapsulated Amalgam Alloy and Dental Mercury (“EAADM”) devices.  The Petitioners, …

    • GAO Issues Report to Aid in MDUFMA ReauthorizationApril 11th, 2007

      The Government Accountability Office (“GAO”) recently released a report detailing the revenue information from certain companies that participate in the Medical Device User Fee Program (“MDUFMA”).  MDUFMA authorizes FDA to charge user fees to review applications for the clearance or approval of medical devices.  MDUFMA …

    • Crossing the Line: Kickbacks Come Under Increased Government ScrutinyApril 9th, 2007

      During the past several years, government enforcement authorities have focused an increasing amount of attention on the marketing activities of medical device companies.  This increased scrutiny has taken the form of investigations through subpoenas and intervention in qui tam lawsuits (lawsuits initiated by a third …

    • WLF Weighs in on FDA Draft Guidances on Laboratory TestsMarch 23rd, 2007

      The Washington Legal Foundation (WLF), a public-interest law and policy center, has challenged FDA’s authority to regulate laboratory developed tests (LDTs), as well as FDA’s proposed method of changing its regulations governing analyte specific reagents (ASRs), which are components of LDTs.  LDTs are commonly referred …